A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer

Inclusion Criteria: * Male aged 21 years or older. * Ability to provide signed informed consent and willingness to comply with protocol requirements. * Past biopsy indicating the presence of adenocarcinoma of the prostate gland. * Participant is deemed to have tissue suspicious of prostate cancer involvement that is amenable to biopsy/resection. * Have had, or will undergo diagnostic CT or MRI imaging prior to surgery. * Participants must agree to use an acceptable form of birth control throughout the study period. Participants must use condoms for a period of seven days after study drug administration, if engaged in sexual activity. Exclusion Criteria: * Participants for whom participating would significantly delay the scheduled standard of care therapy. * Participants administered a radioisotope within 5 physical half lives prior to study enrollment. * Participants with any medical condition or other circumstances that, in the opinion of the investigator, would significantly decrease obtaining reliable data, achieving study objectives or completing the study.